SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Dec 7, 2018
Document Date
Nov 29, 2018
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Chinook Therapeutics, Inc.
Issuer
CHINOOK THERAPEUTICS, INC.
Filer
Hoth Daniel Floyd JR

IR Contact

Novartis Investor Relations

investor.relations@novartis.com

 

MEDIA CONTACT

Novartis Media Relations

media.relations@novartis.com